The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 5, Pages 647
Publisher
MDPI AG
Online
2019-05-13
DOI
10.3390/cancers11050647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
- (2019) Sang R. Lee et al. BMC CANCER
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma
- (2019) Lena Schulte et al. LIVER INTERNATIONAL
- Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation
- (2019) Cong Zhang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis
- (2019) Lin Tuo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MITA1, a novel energy stress-inducible lncRNA, promotes hepatocellular carcinoma metastasis
- (2019) Meilin Ma et al. HEPATOLOGY
- Physcion induces apoptosis through triggering endoplasmic reticulum stress in hepatocellular carcinoma
- (2018) Xiao-ping Pan et al. BIOMEDICINE & PHARMACOTHERAPY
- Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ
- (2018) Mei Han et al. BIOMEDICINE & PHARMACOTHERAPY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin
- (2018) You-Lin Tain et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX
- (2018) Zhen Jiang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib
- (2018) Yuezhao Huang et al. ONCOLOGY REPORTS
- AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
- (2018) Mario D. Cordero et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis
- (2018) Xiaoli Yang et al. Cell Death & Disease
- Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30)
- (2018) Qing Yang et al. MEDICAL SCIENCE MONITOR
- Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway
- (2018) Mei Han et al. ACTA PHARMACOLOGICA SINICA
- Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma
- (2018) Peng Li et al. BIOSCIENCE REPORTS
- Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
- (2018) James S.V. Lally et al. Cell Metabolism
- Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma
- (2018) Zhangjun Cheng et al. GENE
- Knockdown of ZNF233 suppresses hepatocellular carcinoma cell proliferation and tumorigenesis
- (2018) Wenjuan Xie et al. GENE
- Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma
- (2018) Jin Zhou et al. OncoTargets and Therapy
- Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
- (2018) Rong Ke et al. Scientific Reports
- AMPK: a therapeutic target of heart failure—not only metabolism regulation
- (2018) Xuan Li et al. BIOSCIENCE REPORTS
- MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1
- (2018) Yang Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
- (2018) Sofia de Oliveira et al. JOURNAL OF HEPATOLOGY
- NUAK2 is a critical YAP target in liver cancer
- (2018) Wei-Chien Yuan et al. Nature Communications
- The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN)
- (2018) Jianlong Gao et al. MEDICAL SCIENCE MONITOR
- CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma
- (2018) Linpei Wang et al. GENE
- Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
- (2017) Andrea Casadei Gardini et al. EUROPEAN JOURNAL OF CANCER
- Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy
- (2017) Goo-Young Kim et al. HUMAN MOLECULAR GENETICS
- Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner
- (2017) Feng-Shu Hsieh et al. Molecular Oncology
- Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB
- (2017) Min Li et al. ONCOLOGY RESEARCH
- AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1
- (2017) Traci L. Marin et al. Science Signaling
- Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
- (2017) Sin-Ting Wang et al. Cell Death & Disease
- Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
- (2017) Wang Chengye et al. Oncotarget
- A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
- (2017) Xiaoyun Dai et al. Oncotarget
- Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
- (2017) Hsin-Hwa Tsai et al. Oncotarget
- AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1
- (2017) Traci L. Marin et al. Science Signaling
- Treatment of nonalcoholic fatty liver disease: role of AMPK
- (2016) Brennan K. Smith et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The role of AMPK in cardiomyocyte health and survival
- (2016) Suresh C. Bairwa et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Physcion 8- O -β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells
- (2016) Qiang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
- (2016) Danielle K. DePeralta et al. CANCER
- Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
- (2016) Zhigui Guo et al. CANCER SCIENCE
- Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress
- (2016) De Huang et al. CELL RESEARCH
- Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis
- (2016) F. Cauchy et al. CLINICAL SCIENCE
- Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
- (2016) Abin You et al. Journal of Hematology & Oncology
- Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection
- (2016) Young-Seok Seo et al. MEDICINE
- Expression of Phosphorylated AMP-Activated Protein Kinase Predicts Response to Transarterial Chemoembolization in Postoperative Cases of Hepatocellular Carcinoma
- (2016) Long-Yi Zheng et al. MEDICINE
- Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK
- (2016) Chen Shen et al. TUMOR BIOLOGY
- Hepatitis B virus (HBV) X protein-mediated regulation of hepatocyte metabolic pathways affects viral replication
- (2016) Sumedha Bagga et al. VIROLOGY
- Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells
- (2016) Lei Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
- (2016) Mamatha Bhat et al. Oncotarget
- Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
- (2016) Yu Tian et al. Oncotarget
- Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
- (2016) Kaku Goto et al. Oncotarget
- Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma
- (2015) Chi Man Tsang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway
- (2015) Guang-Ming Huang et al. CANCER LETTERS
- Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress
- (2015) Jingtao Zhong et al. CELL PROLIFERATION
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Effects of fucoidan on proliferation, AMP-activated protein kinase, and downstream metabolism- and cell cycle-associated molecules in poorly differentiated human hepatoma HLF cells
- (2015) TAKUMI KAWAGUCHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma
- (2015) Ning Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma
- (2015) Zheng Yun Zhang et al. JOURNAL OF HEPATOLOGY
- Fatsioside A-induced apoptotic death of HepG2 cells requires activation of AMP-activated protein kinase
- (2015) YU-SHAN ZHENG et al. Molecular Medicine Reports
- Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats
- (2015) WOORI JO et al. Molecular Medicine Reports
- Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma
- (2015) JING LI et al. Molecular Medicine Reports
- AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment
- (2015) SONG YI PARK et al. ONCOLOGY REPORTS
- Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression
- (2014) Shu-Ching Hsieh et al. AMINO ACIDS
- AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells
- (2014) Brice Sid et al. BIOCHEMICAL PHARMACOLOGY
- Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma
- (2014) Ning Wang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin
- (2014) Chen-Chieh Yang et al. BMC CANCER
- Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation
- (2014) Rong Yu et al. Cancer Cell International
- Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells
- (2014) Hongmei Qu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma
- (2014) Dong Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
- (2014) HISAAKI MIYOSHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPKα-mediated reduction of DNA methyltransferase 1
- (2014) Yinyi Yie et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Berberine sensitizes rapamycin-mediated human hepatoma cell death in vitro
- (2014) NA GUO et al. Molecular Medicine Reports
- AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
- (2014) Jidong Cheng et al. PLoS One
- Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression
- (2014) Xuejun Yang et al. TUMOR BIOLOGY
- Metformin does not improve survival in patients with hepatocellular carcinoma
- (2014) Mamatha Bhat WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway
- (2013) Yu Xiong et al. Asian Pacific Journal of Cancer Prevention
- A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma
- (2013) Ning Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
- (2013) L. Zheng et al. CLINICAL CANCER RESEARCH
- AMPKbeta subunits: more than just a scaffold in the formation of AMPK complex
- (2013) Pascual Sanz et al. FEBS Journal
- Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
- (2013) GAO YI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- AMPK, insulin resistance, and the metabolic syndrome
- (2013) Neil B. Ruderman et al. JOURNAL OF CLINICAL INVESTIGATION
- The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling
- (2013) Kaku Goto et al. JOURNAL OF HEPATOLOGY
- The regulation and function of the NUAK family
- (2013) Xianglan Sun et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma
- (2013) XIAOLONG YANG et al. Molecular Medicine Reports
- Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo
- (2013) XIANBIN CAI et al. ONCOLOGY REPORTS
- MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
- (2013) Ting-Fang Lo et al. PLoS One
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
- (2012) C.-W. Lee et al. CANCER RESEARCH
- AMP-Activated Protein Kinase Regulation and Biological Actions in the Heart
- (2012) Vlad G. Zaha et al. CIRCULATION RESEARCH
- Hepatoma Cells From Mice Deficient in Glycine N -Methyltransferase Have Increased RAS Signaling and Activation of Liver Kinase B1
- (2012) Nuria Martínez–López et al. GASTROENTEROLOGY
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
- (2012) Zhan Qu et al. HEPATOLOGY RESEARCH
- Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147
- (2011) Qian Hou et al. CANCER SCIENCE
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- AMP-activated protein kinase: also regulated by ADP?
- (2011) D. Grahame Hardie et al. TRENDS IN BIOCHEMICAL SCIENCES
- Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: Synthesis, preliminary structure–activity relationships, and in vitro biological evaluation
- (2010) Xiu-Xiu Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro
- (2010) Shenghua Jie et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- AMP-activated protein kinase: a core signalling pathway in the heart
- (2009) A. S. Kim et al. Acta Physiologica
- Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways
- (2009) Po-Cheng Chiang et al. BIOCHEMICAL PHARMACOLOGY
- Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
- (2009) S. Fogarty et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- AMPK: a key regulator of energy balance in the single cell and the whole organism
- (2008) D G Hardie INTERNATIONAL JOURNAL OF OBESITY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started